| The Cutting Edge: What's New in Male Circumcision |
SUSA14 |
|
|
|
|
| Organiser: |
Jhpiego |
| Type: |
|
Non-Commercial Satellite |
Back
|
|
| Venue: |
MR 1 |
| Time: |
17:00 - 19:00, 17.07.2011 |
| Code: |
SUSA14 |
|
Chair:
|
Kelly Curran, United States
|
|
|
For more than 35 years, Jhpiego has pioneered innovative, low-cost, lifesaving solutions for today's global health concerns, including the prevention of HIV/AIDS. One of the most effective tools that exists today is voluntary medical male circumcision (VMMC).
Compelling evidence indicates that VMMC can reduce the risk of female-to-male transmission of HIV by approximately 60%. VMMC provides a greater protective benefit than any potential vaccine studied to date. Modeling suggests that rapid scale up of VMMC to 80% of adult males in East and Southern Africa would avert more than 3 million new infections and save 416.5 billion in care and treatment costs by 2025. Further, there is evidence that female partners of circumcised men have lower rates of cervical cancer and certain sexually transmitted infections.
Join Jhpiego and its partners from WHO, UNAIDS and the Kenya Ministry of Health for conversation and refreshments.
|
|
Presentations in this session:
17:00
| Welcome
| 17:01
| Introduction
Presented by Kelly Curran, United States
| 17:15
| DVD presentation
| 17:20
Powerpoint | 2007-2011: State of the VMMC scale up
Presented by Catherine Hankins, Switzerland
| 17:30
| Start at the beginning: early infant MC
Presented by Tigistu Adamu, United States
| 17:40
Powerpoint | Adult MC device update and WHO approval process for medical devices
Presented by Tim Farley, Switzerland
| 17:50
| 250,000 circumcisions in 2.5 years
Presented by Peter Cherutich, Kenya
| 18:00
| Matching supply with demand for VMMC
Presented by Hally R Mahler, Tanzania, United Republic of
|
|
| Powerpoints presentations |
| 2007-2011: State of the VMMC scale up - Catherine Hankins | |
| Adult MC device update and WHO approval process for medical devices - Tim Farley | |
|
|